Activities
IPPC Comments - June 2014
IPPC Comments to Federal Trade Commission (FTC) on Consumer Generated and Controlled Health Data
In the pharmaceutical context, data collection and use are essential to provide consumers and caregivers seeking information on medical diseases, conditions and treatments with the information they seek. This may occur, for example, in a digital context through online interactions, through Mobile Health tools such as mobile apps, and through social media or more traditional settings such as over the phone, or at health fairs and clinics. Here, we briefly outline some of the benefits that data collection and use can bring to patients through digital platforms.
Adobe Acrobat Required
More 2014 Activities
-
November
IPPC Comments to U.S. House Energy and Commerce Committee on "21st Century Cures"
-
October
IPPC White Paper on Anonymisation of Clinical Trial Data Sets
-
August
-
August
Joint IPPC and MDPC Comments to US Federal Communications Commission (FCC) on CG Docket No. 05-338
-
July
IPPC Comments to European Commission on mHealth Consultation Paper